What drugs are not eligible for 340B Savings?

January 3, 2022340B, Compliance, Covered Entities, Orphan Drugs

Although the 340B drug pricing program was created by Congress to provide significant discounts on prescription drugs for eligible health care providers, a surprisingly low percentage of providers take advantage of their legal right to use it in reducing costs and filling revenue gaps. As a leading provider of 340B program-management services, we believe the primary … Read More